B
Bertram Pitt
Researcher at University of Michigan
Publications - 834
Citations - 88351
Bertram Pitt is an academic researcher from University of Michigan. The author has contributed to research in topics: Heart failure & Myocardial infarction. The author has an hindex of 107, co-authored 754 publications receiving 78458 citations. Previous affiliations of Bertram Pitt include Rutgers University & Tufts Medical Center.
Papers
More filters
Journal ArticleDOI
Guidelines for the early management of patients with acute myocardial infarction
Rolf M. Gunnar,Patrick D.V. Bourdillon,Donald W. Dixon,Valentin Fuster,Robert B. Karp,J. Ward Kennedy,Francis J. Klocke,Eugene R. Passamani,Bertram Pitt,Elliot Rapaport,T.Joseph Reeves,Richard O. Russell,Burton E. Sobel,William L. Winters,Charles Fisch,George A. Beller,Roman W. DeSanctis,Harold T. Dodge,Sylvan Lee Weinberg +18 more
Journal ArticleDOI
Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial
TL;DR: RLY5016 prevented hyperkalaemia and was relatively well tolerated in patients with HF receiving standard therapy and spironolactone and a non-absorbed, orally administered, potassium [K+]-binding polymer.
Journal ArticleDOI
Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease.
TL;DR: The vasoconstrictive effect of acetylcholine in the angiographically normal coronary arteries of patients with CAD suggests the presence of a diffuse abnormality of endothelial function.
Journal ArticleDOI
Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial.
George L. Bakris,Bertram Pitt,Matthew R. Weir,Mason W. Freeman,Martha Mayo,Dahlia Garza,Yuri Stasiv,Rezi Zawadzki,Lance Berman,David A. Bushinsky +9 more
TL;DR: Patiromer was titrated to achieve and maintain serum potassium level 5.0 mEq/L or lower, which was the most common treatment-related adverse event, mild to moderate constipation, and hypokalemia (<3.3%) over the 52 weeks.
Journal ArticleDOI
Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone.
Amil M. Shah,Brian Claggett,Nancy K. Sweitzer,Sanjiv J. Shah,Inder S. Anand,Li Liu,Bertram Pitt,Marc A. Pfeffer,Scott D. Solomon +8 more
TL;DR: Impaired LS represents a novel imaging biomarker to identify patients with HFpEF at particularly high risk for cardiovascular morbidity and mortality and is a powerful predictor of HF hospitalization, cardiovascular death, or aborted cardiac arrest independent of clinical predictors.